Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

Background/AimsThe dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the pharmacokinetics of a reduced dose of MMF and to validate its feasibility in combination with tacrolimus in living-d...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hyeyoung Kim, Nam-Joon Yi, Juyeun Lee, Joohyun Kim, Mi-Ra Moon, Jaehong Jeong, Jeong-Moo Lee, Tae Suk You, Suk-Won Suh, Min-Su Park, YoungRok Choi, Geun Hong, Hae Won Lee, Kwang-Woong Lee, Kyung-Suk Suh
Format:	Artigo
Idioma:	Inglês
Publicat:	Korean Association for the Study of the Liver 2014-09-01
Col·lecció:	Clinical and Molecular Hepatology
Matèries:	Area under the curve Mycophenolate mofeti Mycophenolic acid Therapeutic drug monitoring Liver transplant
Accés en línia:	http://e-cmh.org/upload/pdf/cmh-20-291.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!